Literature DB >> 18474183

Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension.

Edward D Frohlich1, Dinko Susic.   

Abstract

Obesity and hypertension frequently coexist and are considered major "factors of risk" associated with coronary heart disease. This report identifies the systemic and renal hemodynamic alterations associated with obesity in normotensive and essential hypertensive patients. An expanded intravascular (plasma) volume is associated with obesity, which is related to an increased venous return to the heart, increased cardiac output, and increased blood flow to kidneys and other organs in normal and hypertensive patients. The cardiac consequences result in structural and functional alterations. Although recently postulated pathophysiologic mechanisms have been associated with obesity, none has yet been related to the hemodynamic alterations associated with obesity that coexist in patients with essential hypertension.

Entities:  

Mesh:

Year:  2008        PMID: 18474183     DOI: 10.1007/s11906-008-0028-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  52 in total

Review 1.  Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy.

Authors:  G de Simone; F Pasanisi; F Contaldo
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

Review 2.  Obesity-associated hypertension: new insights into mechanisms.

Authors:  Kamal Rahmouni; Marcelo L G Correia; William G Haynes; Allyn L Mark
Journal:  Hypertension       Date:  2004-12-06       Impact factor: 10.190

Review 3.  Renal Parenchymal Hypertension: current concepts of pathogenesis and management.

Authors:  R A Preston; I Singer; M Epstein
Journal:  Arch Intern Med       Date:  1996-03-25

4.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

5.  Hemodynamics and other determinants in development of left ventricular hypertrophy.

Authors:  E D Frohlich
Journal:  Fed Proc       Date:  1983-07

Review 6.  Obesity and renal hemodynamics.

Authors:  R J Bosma; J A Krikken; J J Homan van der Heide; P E de Jong; G J Navis
Journal:  Contrib Nephrol       Date:  2006       Impact factor: 1.580

7.  Dimorphic cardiac adaptation to obesity and arterial hypertension.

Authors:  F H Messerli; K Sundgaard-Riise; E D Reisin; G R Dreslinski; H O Ventura; W Oigman; E D Frohlich; F G Dunn
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

8.  Weight loss in combination with physical activity improves endothelial dysfunction in human obesity.

Authors:  Angela Sciacqua; Mafalda Candigliota; Roberto Ceravolo; Angela Scozzafava; Flora Sinopoli; Andrea Corsonello; Giorgio Sesti; Francesco Perticone
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

9.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

10.  Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril.

Authors:  P G Schmitz; M P O'Donnell; B L Kasiske; S A Katz; W F Keane
Journal:  Am J Physiol       Date:  1992-09
View more
  5 in total

Review 1.  Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.

Authors:  Eric J Belin de Chantemele; David W Stepp
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

2.  The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction.

Authors:  Dmitry Abramov; Kun-Lun He; Jie Wang; Daniel Burkhoff; Mathew S Maurer
Journal:  J Card Fail       Date:  2011-05-06       Impact factor: 5.712

Review 3.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

4.  Plasma adiponectin and the risk of hypertension in white and black postmenopausal women.

Authors:  Lu Wang; JoAnn E Manson; J Michael Gaziano; Simin Liu; Barbara Cochrane; Nancy R Cook; Paul M Ridker; Nader Rifai; Howard D Sesso
Journal:  Clin Chem       Date:  2012-08-02       Impact factor: 8.327

5.  Baseline characteristics predicting clinical outcomes and serious adverse events in middle-aged hypertensive women: a subanalysis of the SPRINT in women aged <65 years

Authors:  Volkan Aydin; Ahmet Akici; Sibel Sakarya; Mehmet Akman; Ali Serdar Fak
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.